Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 57, n° 4
pages 659-664 (octobre 2007)
Doi : 10.1016/j.jaad.2007.02.011
Dermatologic Surgery

Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma
 

Hobart W. Walling, MD, PhD a, , Richard K. Scupham, MD, PhD b, Andrew K. Bean, MD a, Roger I. Ceilley, MD a
a Private practice, Dermatology, PC, West Des Moines, Iowa 
b Iowa Pathology Associates, Des Moines, Iowa 

Reprint requests: Hobart W. Walling, MD, PhD, 6000 University Ave, West Des Moines, IA 50266.
Abstract
Background

Lentigo maligna (LM) is a relatively common tumor with increasing prevalence and substantial morbidity. A variety of treatment modalities are available, though margin-control surgery offers the highest cure rate. We were interested in comparing long-term outcomes of Mohs micrographic surgery (MMS) versus staged excision with permanent sections (SE) for treating LM or LM melanoma (LMM).

Methods

Comparative study consisting of retrospective chart review from our private practice.

Results

Fifty-seven patients (31 male, 26 female, mean age at diagnosis 69.1 ± 10.1 years) were treated in our office for LM (50) or LMM (9) between January 1986 and December 2001. Forty-one tumors (71%) were located on the head and neck. Fifty-three of the 59 tumors (90%) were primary, and 6/59 (10%) were recurrent at the time of initial treatment. Forty-one tumors (36 LM, 5 LMM) were treated with SE, and 18 (14 LM, 4 LMM) were treated with MMS. The mean preoperative lesion size (1.5 ± 0.2 cm2 for SE; 1.2 ± 0.4 cm2 for MMS), mean postoperative defect size (7.1 ± 1 cm2 for SE; 7.1 ± 1.4 cm2 for MMS), and the ratio of postoperative defect to preoperative lesion size (7.9-fold increase for SE, 11.2-fold increase for MMS) were similar between the cohorts. Mean number of stages for clear margins were similar, with 1.8 ± 0.2 stages (range: 1-7) for SE and 2.0 ± 0.2 stages (range: 1-4) for MMS; clear margins were obtained in one or two stages in 85% of cases for SE and in 67% for MMS. Three recurrences (3/41; 7.3%) occurred in the SE group while 6 recurrences (6/18; 33%) occurred in the MMS group (P < .025). The mean follow-up duration was 95 months (range: 60-240) in the SE group and 117.5 months (range: 61-157) in the MMS group.

Limitations

Results are limited to a single practice site and fewer patients underwent MMS compared to SE. Patients were not randomized as cases were ascertained retrospectively.

Conclusion

Staged excision of LM and LMM is associated with a significantly lower recurrence rate with no difference in surgical defect size compared to MMS. To our knowledge, this is the first study directly comparing these two surgical techniques for managing this form of melanoma. Our extended follow-up duration exceeds that of most previous reports.

The full text of this article is available in PDF format.

 Funding sources: None.
 Conflicts of interest: None declared.
 Presented at the American College of Mohs Micrographic Surgery and Cutaneous Oncology 38th annual meeting, Scottsdale, AZ, April 28-30, 2006.



© 2007  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline